These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

295 related items for PubMed ID: 9486676

  • 21. Serum soluble interleukin-2 receptor (sIL-2R) level is associated with the outcome of patients with diffuse large B cell lymphoma treated with R-CHOP regimens.
    Goto N, Tsurumi H, Goto H, Shimomura YI, Kasahara S, Hara T, Yasuda I, Shimizu M, Murakami N, Yoshikawa T, Fukuno K, Takahashi T, Kito Y, Takami T, Moriwaki H.
    Ann Hematol; 2012 May; 91(5):705-714. PubMed ID: 22183251
    [Abstract] [Full Text] [Related]

  • 22. Constitutive secretion of soluble interleukin-2 receptor by human T cell lymphoma xenografted into SCID mice. Correlation of tumor volume with concentration of tumor-derived soluble interleukin-2 receptor in body fluids of the host mice.
    Wasik MA, Sioutos N, Tuttle M, Butmarc JR, Kaplan WD, Kadin ME.
    Am J Pathol; 1994 May; 144(5):1089-97. PubMed ID: 8178932
    [Abstract] [Full Text] [Related]

  • 23. A high sIL-2R/ferritin ratio is a useful marker for the diagnosis of lymphoma-associated hemophagocytic syndrome.
    Tsuji T, Hirano T, Yamasaki H, Tsuji M, Tsuda H.
    Ann Hematol; 2014 May; 93(5):821-6. PubMed ID: 24705932
    [Abstract] [Full Text] [Related]

  • 24. Soluble interleukin-2 receptor in Sézary syndrome: its origin and clinical application.
    Bernengo MG, Fierro MT, Novelli M, Lisa F, Appino A.
    Br J Dermatol; 1993 Feb; 128(2):124-9. PubMed ID: 8457444
    [Abstract] [Full Text] [Related]

  • 25. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T, Sugaya M, Suga H, Ohmatsu H, Fujita H, Asano Y, Tada Y, Kadono T, Sato S.
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [Abstract] [Full Text] [Related]

  • 26. Serum amyloid A levels in the blood of patients with atopic dermatitis and cutaneous T-cell lymphoma.
    Suzuki H, Sugaya M, Nakajima R, Oka T, Takahashi N, Nakao M, Miyagaki T, Asano Y, Sato S.
    J Dermatol; 2018 Dec; 45(12):1440-1443. PubMed ID: 30289574
    [Abstract] [Full Text] [Related]

  • 27. Serum level of a soluble receptor for interleukin-2 as a prognostic factor in patients with gastric cancer.
    Saito H, Tsujitani S, Ikeguchi M, Maeta M, Kaibara N.
    Oncology; 1999 Apr; 56(3):253-8. PubMed ID: 10202282
    [Abstract] [Full Text] [Related]

  • 28. Biopsy of cervical lymph node.
    Matsumoto F, Itoh S, Ohba S, Yokoi H, Furukawa M, Ikeda K.
    Auris Nasus Larynx; 2009 Feb; 36(1):71-4. PubMed ID: 18479855
    [Abstract] [Full Text] [Related]

  • 29. The clinical significance of serum soluble interleukin 2 receptor (sIL-2R) concentration in lung cancer.
    Naumnik W, Chyczewska E.
    Folia Histochem Cytobiol; 2001 Feb; 39 Suppl 2():185-6. PubMed ID: 11820599
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. High level of soluble interleukin-2 receptor in serum predicts treatment resistance and poor progression-free survival in multiple myeloma.
    Wang L, Wang JH, Liu WJ, Wang WD, Wang H, Chen XQ, Geng QR, Lu Y, Xia ZJ.
    Ann Hematol; 2017 Dec; 96(12):2079-2088. PubMed ID: 28871325
    [Abstract] [Full Text] [Related]

  • 36. Serum levels of interleukin-18 (IL-18) and soluble interleukin-2 receptor (sIL-2R) in lung cancer.
    Naumnik W, Chyczewska E, Kovalchuk O, Tałałaj J, Izycki T, Panek B.
    Rocz Akad Med Bialymst; 2004 Dec; 49():246-51. PubMed ID: 15631351
    [Abstract] [Full Text] [Related]

  • 37. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A, Leonardi E, Simeone E, Ascierto PA, Scala S, Calemma R, Bryce J, Caracò C, Satriano RA, Gianfranco N, Franco R, Botti G, Castello G.
    Cytokine; 2006 Feb 07; 33(3):150-5. PubMed ID: 16517174
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.